Understanding GLP-1 Medications: GLP-1 medications, or glucagon-like peptide-1 receptor agonists, represent a class of injectable drugs originally developed to manage type 2 diabetes and obesity
It was originally created in the 1990s to treat rare genetic diseases and skin conditions but, as with many medications, has grown in popularity for its myriad of off-label uses
Kumar N, Liu S, Kozlowski PM
These active peptides can promote insulin secretion in a glucose-dependent manner.
The complex process leading to the production of these multiple species of GLP-1 affords multiple levels of control over what is ultimately secreted by the cell
Glutathione works by mopping up something called free radicals, which are unstable atoms that can cause cell damage